Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ACTRN12626001196336) titled 'A Randomized, Double-Blind, Placebo-Controlled, Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of BMB-105 in Fed and Fasted Adult Healthy Human Volunteers' on Sept. 28.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Primary Sponsor: Bright Minds Biosciences Pty Ltd
Condition:
Prader-Willi Syndrome (PWS)
Prader-Willi Syndrome (PWS)
Human Genetics and Inherited Disorders - Other human genetics and inherited disorders
Intervention:
Pa...